Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Guido Krenning
Has grant
Principle Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Mitochondrial Medicines against Acute Kidney Injury
Open Date: 2019-01-01
Close Date: 2024-01-01
Grant: Close
Endothelial Plasticity: the Culprit of Fibroproliferative Disease
Open Date: 2016-06-01
Close Date: 2021-06-01
Grant: Close
Defeating glomerulosclerosis by targeting Ezh2 (DELETE)
Open Date: 2015-09-01
Close Date: 2019-08-01
Grant: Close
Action and mechanism of SUL-109 on Adipose Tissue-derived Stem Cells
Open Date: 2015-01-01
Close Date: 2015-01-01
Grant: Close
MicroRNA dysregulation in cardiac endothelial cells: contribution to cardiac fibrosis and potential for therapy
Open Date: 2010-01-01
Close Date: 2013-12-01
Articles (20)
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Ben N. G. Giepmans
Scientific Staff
University Medical Center Groningen
Tom van Meerten
University of Groningen
Rick Oerlemans
University of Groningen
Jenny A Visser
Associate professor
Erasmus University Rotterdam
ingrid garrelds
Erasmus University Rotterdam
Jasper Stevens
University Medical Center Groningen
Anton J.M. Roks
Associate professor
Erasmus University Medical Center
marian clahsen-van groningen
Guest Professorship
RWTH Aachen University
Martin C Harmsen
University of Groningen
Ton Rabelink
professor
Leiden University
Bart G. J. Dekkers
University Medical Center Groningen
Robert Henning
Professor of Pharmacology
University Medical Center Groningen
Make your next move.
Prepare your application
Review drafts before you send them.